周三盘前，吉利德科学（GILD）股价大幅下跌5.03%，引发市场关注。这一跌势主要源于美国总统特朗普再次威胁对进口药品征收"重大"关税。
据报道，特朗普重申计划对所有药品进口征收关税，这是继其"对等"关税生效后的又一举措。此前，在上周宣布的第一轮"互惠"关税中，制药产品曾被豁免。特朗普表示，征收关税将激励制药公司将业务转移回美国。
这一消息不仅影响了吉利德科学，多家美国制药巨头股价也在盘前出现下跌。例如，礼来公司下跌1.5%，百健下跌1.1%，辉瑞下跌1.1%。然而，券商BMO Capital Markets指出，对药品征收关税"可能不会对制造业回流美国产生多大影响"，因为美国已经拥有强大的生物制造和在岸加工能力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.